CNO Financial Group filings document the insurance holding company's operating results, governance and capital actions. Form 8-K reports furnish quarterly financial results, financial supplements and operating presentations covering life and health insurance, annuities, distribution activity, investment results and capital management.
Proxy and governance filings address annual meeting voting items, director elections, board committee matters, executive compensation and director compensation. Other material-event reports disclose dividend declarations, board appointments or retirements, Regulation FD presentations and securities identified in the company's capital structure.
CNO Financial Group, Inc. (CNO) reported that Chief Actuary Jeremy D. Williams exercised employee stock options and sold the resulting common shares in mid-September 2026. On September 15 and 16, he exercised options for a total of 7,660 shares and sold 8,782 shares of common stock pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026.
CNO Financial Group, Inc. (CNO) received a notice that officer Jeremy David Williams intends to sell Common Stock under Rule 144. The notice covers 4,362 shares with an aggregate market value of $243,029.65, relative to 92,521,371 shares outstanding, with sales expected to begin on September 16, 2026. The shares to be sold include 1,122 shares from performance shares acquired on February 10, 2026 and 3,240 shares from a stock option exercise on September 16, 2026. Williams previously sold 4,420 shares on June 15, 2026 for $244,291.63.
CNO Financial Group, Inc. (CNO) received a Rule 144 notice that officer Jeremy Williams plans to sell common stock. The planned sale involves 4,420 shares of CNO common stock through Morgan Stanley Smith Barney LLC in connection with a stock option exercise on September 15, 2026.
CNO Financial Group, Inc. (CNO) chief operations officer Jeanne L. Linnenbringer reported an option exercise and related stock sales. On August 31, 2026, she exercised employee stock options for 5,010 shares of common stock at an exercise price of $23.33 per share, from options that had vested in 2020 and 2021, and sold those 5,010 shares plus an additional 1,550 shares at weighted average prices around $54.99. She then sold 4,060 shares on September 1, 2026 at a weighted average price of $54.73 and 3,919 shares on September 2, 2026 at a weighted average price of $55.11, for total reported sales of 14,539 shares. All reported sales were made in open-market transactions pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026.
CNO Financial Group, Inc. (CNO) reports that Karen J. DeToro, President of the Worksite Division, exercised stock options and sold shares of common stock. On August 31 and September 1, 2026, she exercised options covering 15,000 shares at an exercise price of $15.83 per share, receiving common stock. Between August 31 and September 2, 2026, she sold an aggregate of 24,674 shares of common stock in open-market transactions at weighted average prices around the mid‑$54 to mid‑$55 range, including 5,964 shares at $55.1188 per share on September 2, 2026. All reported sales were made pursuant to a Rule 10b5‑1 trading plan adopted on May 11, 2026.
CNO Financial Group, Inc. (CNO) has a filing indicating that officer Karen DeToro plans to sell 5,964 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC, with an aggregate market value of $328,728.52 as of the notice date.
The notice also lists prior sales by DeToro in the last three months totaling 9,336 shares on September 1, 2026 for $511,002.96 and 9,374 shares on August 31, 2026 for $515,366.21. The shares to be sold were acquired upon vesting of restricted stock and Performance Shares between January 2, 2025 and February 11, 2025.
CNO Financial Group, Inc. (CNO) is the issuer of common stock for which officer Jeanne Lynn Linnenbringer has filed a notice of proposed sales under Rule 144. The filing covers 3,919 shares to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an estimated aggregate sale price of $215,979.62 as of September 2, 2026. The securities were acquired upon vesting of restricted stock and Performance Shares during the period from March 25, 2021 through March 25, 2025, and follow recent sales in the prior three months.
CNO Financial Group, Inc. (CNO) is the issuer for a planned resale of common stock under Rule 144 by officer Jeanne Linnenbringer. The filing indicates an intended sale of 4,060 shares of CNO common stock through Morgan Stanley Smith Barney, with an aggregate market value of $222,207.05 and 92,521,371 shares outstanding. The securities were acquired upon vesting of performance shares during the period from February 15, 2022 through February 11, 2025. Over the prior three months, Linnenbringer sold 6,560 shares of CNO common stock for proceeds of $360,715.51.
CNO Financial Group, Inc. (CNO) disclosed that officer Karen DeToro filed a notice to sell CNO common stock under Rule 144. She lists 9,336 shares of common stock held through Morgan Stanley Smith Barney Executive Financial Services, with an indicated value of $511,002.96 as of September 1, 2026. Planned sales include 1,836 shares from restricted stock dated March 25, 2025 and 7,500 shares issuable upon a stock option exercise dated September 1, 2026. The notice also reports a prior sale of 9,374 shares on August 31, 2026 for $515,366.21.
CNO Financial Group, Inc. (CNO) furnished an investor briefing focused on its Worksite Division and Medicare business, highlighting its middle‑income market strategy and distribution model. The company employs approximately 3,200 associates, contracts with over 11,500 agents and independent partners, has a $5.1 billion market capitalization, and reports $39.9 billion in total assets as of June 30, 2026. Customers own 3.3 million policies, and CNO paid $2.1 billion in claims in 2025.
The Worksite Division targets employers with predominantly middle‑income workforces, with almost 70% of new annualized premium (NAP) from transit and utilities, education, and public sector employers, and has grown Worksite NAP at an 18% CAGR since 2020. CNO emphasizes supplemental health and life products, including return‑of‑premium features that have returned nearly $5 billion of premium to policyholders since inception.
In Medicare, CNO describes a large, growing market of over 69 million beneficiaries, with Medicare spending above $1.2 trillion. CNO distributes its own Medicare Supplement plans and a wide range of third‑party Medicare Advantage and prescription drug plans through more than 5,000 captive health insurance agents, and presents data on growing Medicare Supplement enrollment, earned premiums and underwriting margins.